Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results 2025 NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results 2025 NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results 2025 NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results 2025 NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM in your area.
In patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8
26.95
Frontiers
21.07
Oral Semaglutide Reduces Cardiovascular Risk in Type 2 Diabetes: Results from SOUL Trial
26.17
Canadian Perspectives 2025 Whiteboard on the SOUL Trial
26.15
Frontiers
29.67
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study | Diabetes Therapy
22.71
Journal club: SOUL Study – CVOT for Oral Semaglutide Full Title: Cardiovascular Outcomes Trial of Oral Semaglutide in Subjects with Type 2 Diabetes กองอายุรกรรม รพ พระมงกุฎเกล้า
22.59
